MedPath

The Safety and Efficacy of 1064-nm Picosecond Laser With Microlens Array for Pore Tightening; a Pilot Study

Not Applicable
Conditions
Enlarged Pores
Interventions
Device: Fractional picosecond 1064 nm laser
Registration Number
NCT04471948
Lead Sponsor
Mahidol University
Brief Summary

The objective of this study is to evaluate the safety and efficacy of 1064-nm Picosecond laser 1064 With Microlens Array for Pore tightening.

Detailed Description

The Safety and Efficacy of Picosecond laser 1064 Nanometers With Microlens Array for Pore tightening; a Pilot Study Primary outcome : pore size Secondary outcome : side effect, patient satisfaction, global evaluation the patient recieved laser treament once a month for 3 months and then follow up after last treatment at 1, 3 ,6 month

Enlarged facial pores is one of the skin signs in photoaging. There are 3 major clinical causes of enlarged facial pores: highs sebum excretion, decreased elasticity around pores and increased hair follicle volume. Possible causative factors of enlarged facial pores include many exogenous and endogenous factors include genetic predisposition, seborrhea and chronic ultraviolet light exposure. Picosecond laser are new device which has been used in skin rejuvenation. The main mechanism of action is laser induced optical breakdown (LIOB).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
26
Inclusion Criteria
  • Both male and female age 25-40 years
  • No underlying disease
Exclusion Criteria
  • History of retinoid or other keratolytic drugs used within 6 months before enrolled
  • History of keloid
  • photosensitivity
  • Immunocompromised host

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Fractional picosecond laser 1,064 nm laserFractional picosecond 1064 nm laser1 arm The subjects with enlarged pores were treated with fractional picosecond laser 1,064 nm laser
Primary Outcome Measures
NameTimeMethod
Change in pore size by Antera 3D imagechange from baseline in pore size at 6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Dermatology, Siriraj Hospital, Mahidol University

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath